Authors:
BOULIEU R
LEHMANN B
SALORD F
FISHER C
MORLET D
Citation: R. Boulieu et al., PHARMACOKINETICS OF MIDAZOLAM AND ITS MAIN METABOLITE 1-HYDROXYMIDAZOLAM IN INTENSIVE-CARE PATIENTS, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 255-258
Authors:
GAULIER JM
BOULIEU R
FISCHER C",MAUGUIERE
Citation: Jm. Gaulier et al., EVALUATION OF A BAYESIAN PHARMACOKINETIC PROGRAM FOR PHENYTOIN CONCENTRATION PREDICTIONS IN OUTPATIENT POPULATION, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 295-300
Citation: T. Dervieux et R. Boulieu, SIMULTANEOUS DETERMINATION OF 6-THIOGUANINE AND METHYL 6-MERCAPTOPURINE NUCLEOTIDES OF AZATHIOPRINE IN RED-BLOOD-CELLS BY HPLC, Clinical chemistry, 44(3), 1998, pp. 551-555
Citation: S. Bolze et R. Boulieu, HPLC DETERMINATION OF KETAMINE, NORKETAMINE, AND DEHYDRONORKETAMINE IN PLASMA WITH A HIGH-PURITY REVERSED-PHASE SORBENT, Clinical chemistry, 44(3), 1998, pp. 560-564
Citation: R. Boulieu et al., DETERMINATION OF ACYCLOVIR IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 693(1), 1997, pp. 233-236
Citation: R. Boulieu et al., INTRACELLULAR THIOPURINE NUCLEOTIDES AND AZATHIOPRINE MYELOTOXICITY IN ORGAN TRANSPLANT PATIENTS, British journal of clinical pharmacology, 43(1), 1997, pp. 116-118
Authors:
MORLET D
BERTRAND O
SALORD F
BOULIEU R
PERNIER J
FISCHER C
Citation: D. Morlet et al., DYNAMICS OF MLAEP CHANGES IN MIDAZOLAM-INDUCED SEDATION, Electroencephalography and clinical neurophysiology. Evoked potentials, 104(5), 1997, pp. 437-446
Citation: R. Boulieu et al., PHARMACOKINETICS OF ACYCLOVIR IN PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMODIALYSIS, Therapeutic drug monitoring, 19(6), 1997, pp. 701-704
Authors:
GAULIER JM
BOULIEU R
FISCHER C
MAUGUIERE F
Citation: Jm. Gaulier et al., PREDICTIONS OF CARBAMAZEPINE CONCENTRATIONS USING A BAYESIAN PROGRAM (PKS SYSTEM, ABBOTT) - A RETROSPECTIVE EVALUATION IN AN OUTPATIENT POPULATION, Journal of Pharmacy and Pharmacology, 49(7), 1997, pp. 734-736
Citation: C. Bory et al., COMPARISON OF CAPILLARY ELECTROPHORETIC AND LIQUID-CHROMATOGRAPHIC DETERMINATION OF HYPOXANTHINE AND XANTHINE FOR THE DIAGNOSIS OF XANTHINURIA, Journal of chromatography, 730(1-2), 1996, pp. 329-331
Citation: R. Boulieu, SAMPLE PREPARATION FOR THE DETERMINATION OF PURINE NUCLEOTIDE ANALOGSIN TISSUES, Journal of chromatography, 729(1-2), 1996, pp. 197-200
Authors:
BASTIEN O
BOULIEU R
BLEYZAC N
BOISSONNAT P
GARRE JP
DUREAU G
Citation: O. Bastien et al., GANCICLOVIR USE DURING MILD RENAL-FAILURE IN HEART-TRANSPLANTATION, Transplantation proceedings, 28(5), 1996, pp. 2876-2877
Citation: C. Chantin et al., LIQUID-CHROMATOGRAPHIC STUDY OF PURINE METABOLISM ABNORMALITIES IN PURINE NUCLEOSIDE PHOSPHORYLASE-DEFICIENCY, Clinical chemistry, 42(2), 1996, pp. 326-328
Citation: B. Lehmann et R. Boulieu, DETERMINATION OF MIDAZOLAM AND ITS UNCONJUGATED 1-HYDROXY METABOLITE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 674(1), 1995, pp. 138-142
Citation: R. Boulieu et A. Lenoir, DETERMINATION OF THIOPURINE NUCLEOTIDES IN HUMAN LUNG-TISSUE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 665(1), 1995, pp. 213-216
Citation: R. Boulieu, SOLID-PHASE EXTRACTION METHOD FOR THE DETERMINATION OF DILTIAZEM AND ITS METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - FACT OR FALLACY, Journal of chromatography B. Biomedical applications, 660(1), 1994, pp. 221-222
Citation: N. Bleyzac et R. Boulieu, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GANCICLOVIR NUCLEOTIDES IN HUMAN MYOCARDIAL TISSUE, Journal of chromatography B. Biomedical applications, 658(1), 1994, pp. 173-176
Citation: R. Boulieu et N. Bleyzac, STABILITY OF GANCICLOVIR IN BLOOD-SAMPLES, Journal of pharmaceutical and biomedical analysis, 12(9), 1994, pp. 1205-1207
Citation: O. Bastien et al., CLINICAL USE OF GANCICLOVIR DURING RENAL-FAILURE AND CONTINUOUS HEMODIALYSIS, Intensive care medicine, 20(1), 1994, pp. 47-48
Authors:
COMBARNOUS F
FOUQUE D
BERNARD N
BOULIEU R
CHOSSEGROS P
LAVILLE M
ZECH P
Citation: F. Combarnous et al., PHARMACOKINETICS OF GANCICLOVIR IN A PATIENT UNDERGOING CHRONIC-HEMODIALYSIS, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 379-381
Authors:
BOULIEU R
BONNEFOUS JL
LEHOT JJ
DURAND PG
CHASSIGNOLLE JF
FERRY S
Citation: R. Boulieu et al., EFFECT OF CARDIOPULMONARY BYPASS ON PLASMA-CONCENTRATIONS OF DILTIAZEM AND ITS 2 ACTIVE METABOLITES, Journal of Pharmacy and Pharmacology, 46(4), 1994, pp. 310-312
Authors:
LEHOT JJ
DURAND PG
BOULIEU R
BONNEFOUS JL
FLAMENS C
HERCULE C
DUGRES B
VILLARD J
FERRY S
ESTANOVE S
Citation: Jj. Lehot et al., PLASMA-CONCENTRATIONS OF DILTIAZEM AND IT S ACTIVE METABOLITES IN CORONARY-ARTERY SURGERY - RELATIONSHIP WITH PREOPERATIVE TREATMENT, Annales francaises d'anesthesie et de reanimation, 12(5), 1993, pp. 452-456
Citation: R. Boulieu et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THIOPURINE METABOLITES OF AZATHIOPRINE IN BIOLOGICAL-FLUIDS, Journal of chromatography. Biomedical applications, 615(2), 1993, pp. 352-356
Citation: Jj. Lehot et al., PROBLEMS RAISED BY CALCIUM-ANTAGONISTS AN D ANESTHESIA - PHARMACOLOGY, INTERACTIONS, INDICATIONS, Annales de cardiologie et d'angeiologie, 42(8), 1993, pp. 431-437